Close
Smartlab Europe
Inizio Ignite

Boston Analytical Continues Expansion with Office in Cambridge MA

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data

Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.
- Advertisement -

Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes two years after opening a 30,000 square foot, state-of-the-art facility in Salem, NH, and one year after opening a 5,000 square foot laboratory specifically for its ever growing protein characterization services.

This move is a logical expansion for Boston Analytical, which has experienced double-digit growth over the past five years. The new location is in the heart of the Cambridge Life Sciences Corridor, a geography occupied by hundreds of life science companies. Kristin Dangelo, Director of Business Development, noted, “The Cambridge office provides Boston Analytical proximity to many of the organizations we serve.”

The new office is located at 1 Broadway Street. This location offers many amenities to a highly educated work force, and is an easy commute from Boston Analytical’s facility in Salem, New Hampshire.

About Boston Analytical: Boston Analytical, the Life Sciences division of Alpha Analytical, is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 certified analytical laboratory located in Salem, NH. Boston Analytical provides testing services to Pharmaceutical and Medical Device companies worldwide including Analytical Testing and Method Development, Protein Chemistry Studies, Microbiological Testing and EM Services, Stability Testing & ICH-compliant Storage, and Extractables & Leachables Studies.

Latest stories

Related stories

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data

Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.

The Strategic Value of Editorially Curated Drug Databases

While raw data is abundant, the strategic value of drug information lies in editorial curation, ensuring that every interaction, dosage, and safety alert is verified by experts.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »